GlaxoSmithKline Net Income (2009-2013) | Financial Performance Chart #1646403 (License: Personal Use)

This bar chart displays GlaxoSmithKline’s annual net income in billions of U.S. dollars from 2009 through 2013, revealing strong profitability in most years except 2010 and 2011, when the company reported losses of approximately $0.4B and $0.8B respectively-likely tied to legal settlements or restructuring costs. The data, sourced from Factset and visualized by Quartz, shows a rebound starting in 2012, with income stabilizing near $1.5-2.0B through 2013.

Used in financial analysis articles, investor reports, or pharmaceutical industry reviews to illustrate corporate profitability trends; matches user intent seeking historical earnings performance of GSK for benchmarking or investment research.